Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Active Pharmaceutical Ingredients
Revenue, means the sales value of Active Pharmaceutical Ingredients
This report studies Active Pharmaceutical Ingredients in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Sun Pharmaceutical Industries
DSM
Hisun Pharmacy
Huahai Pharmaceutical
North China Pharmaceutical Group
Shandong Lukang Pharmaceutical
Haerbin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Jiangsu Hengrui Medicine
Lonza Group
Aurobindo Pharma
Lupin
Biocon
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Synthetic APIs
Biotech APIs
Split by Application, this report focuses on consumption, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other
China Active Pharmaceutical Ingredients Market Research Report 2017
1 Active Pharmaceutical Ingredients Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Active Pharmaceutical Ingredients Segment by Type
1.2.1 China Production Market Share of Active Pharmaceutical Ingredients Type in 2015
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Applications of Active Pharmaceutical Ingredients
1.3.1 Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other
1.4 China Market Size (Value) of Active Pharmaceutical Ingredients (2012-2022)
1.5 China Active Pharmaceutical Ingredients Status and Outlook
1.6 Government Policies
2 China Active Pharmaceutical Ingredients Market Competition by Manufacturers
2.1 China Active Pharmaceutical Ingredients Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Active Pharmaceutical Ingredients Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Active Pharmaceutical Ingredients Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area, Product Type
2.5 Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredients Market Concentration Rate
2.5.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
3 China Active Pharmaceutical Ingredients Manufacturers Profiles/Analysis
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.1.2.1 Synthetic APIs
3.1.2.2 Biotech APIs
3.1.3 Pfizer Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Novartis International
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.2.2.1 Synthetic APIs
3.2.2.2 Biotech APIs
3.2.3 Novartis International 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Sanofi
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.3.2.1 Synthetic APIs
3.3.2.2 Biotech APIs
3.3.3 Sanofi 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Boehringer Ingelheim
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.4.2.1 Synthetic APIs
3.4.2.2 Biotech APIs
3.4.3 Boehringer Ingelheim Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Bristol-Myers Squibb
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.5.2.1 Synthetic APIs
3.5.2.2 Biotech APIs
3.5.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Teva Pharmaceutical
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.6.2.1 Synthetic APIs
3.6.2.2 Biotech APIs
3.6.3 Teva Pharmaceutical Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Eli Lilly and Company
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.7.2.1 Synthetic APIs
3.7.2.2 Biotech APIs
3.7.3 Eli Lilly and Company Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 GlaxoSmithKline
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.8.2.1 Synthetic APIs
3.8.2.2 Biotech APIs
3.8.3 GlaxoSmithKline Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Merck & Co
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.9.2.1 Synthetic APIs
3.9.2.2 Biotech APIs
3.9.3 Merck & Co Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 AbbVie
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
3.10.2.1 Synthetic APIs
3.10.2.2 Biotech APIs
3.10.3 AbbVie Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Johnson & Johnson
3.12 Bayer
3.13 Sun Pharmaceutical Industries
3.14 DSM
3.15 Hisun Pharmacy
3.16 Huahai Pharmaceutical
3.17 North China Pharmaceutical Group
3.18 Shandong Lukang Pharmaceutical
3.19 Haerbin Pharmaceutical Group
3.20 Shandong Xinhua Pharmaceutical
3.21 Jiangsu Hengrui Medicine
3.22 Lonza Group
3.23 Aurobindo Pharma
3.24 Lupin
3.25 Biocon
4 China Active Pharmaceutical Ingredients Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Active Pharmaceutical Ingredients Capacity, Production and Growth (2012-2017)
4.2 China Active Pharmaceutical Ingredients Revenue and Growth (2012-2017)
4.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)
5 China Active Pharmaceutical Ingredients Production, Revenue (Value), Price Trend by Type
5.1 China Active Pharmaceutical Ingredients Production and Market Share by Type (2012-2017)
5.2 China Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
5.3 China Active Pharmaceutical Ingredients Price by Type (2012-2017)
5.4 China Active Pharmaceutical Ingredients Production Growth by Type (2012-2017)
6 China Active Pharmaceutical Ingredients Market Analysis by Application
6.1 China Active Pharmaceutical Ingredients Consumption and Market Share by Application (2012-2017)
6.2 China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaActive Pharmaceutical Ingredients Market Analysis by Regions (Provinces)
7.1 China Active Pharmaceutical Ingredients Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Active Pharmaceutical Ingredients Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Active Pharmaceutical Ingredients Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Active Pharmaceutical Ingredients Sales Price by Regions (Provinces)(2012-2017)
7.2 China Active Pharmaceutical Ingredients Consumption by Regions (Provinces)(2012-2017)
7.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)
8 Active Pharmaceutical Ingredients Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Active Pharmaceutical Ingredients Market Forecast (2017-2022)
12.1 China Active Pharmaceutical Ingredients Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Active Pharmaceutical Ingredients Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Active Pharmaceutical Ingredients Production Forecast by Type (2017-2022)
12.4 China Active Pharmaceutical Ingredients Consumption Forecast by Application (2017-2022)
12.5 China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Active Pharmaceutical Ingredients Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Active Pharmaceutical Ingredients Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Active Pharmaceutical Ingredients Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Active Pharmaceutical Ingredients
Figure China Production Market Share of Active Pharmaceutical Ingredients by Type in 2015
Figure Product Picture of Synthetic APIs
Table Major Manufacturers of Synthetic APIs
Figure Product Picture of Biotech APIs
Table Major Manufacturers of Biotech APIs
Table Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015
Figure Oncology Examples
Figure Diabetes Examples
Figure Cardiovascular Disease Examples
Figure CNS and Neurological Disorders Examples
Figure Endocrinology Examples
Figure Other Examples
Figure China Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)
Table China Active Pharmaceutical Ingredients Capacity of Key Manufacturers (2015 and 2016)
Table China Active Pharmaceutical Ingredients Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Active Pharmaceutical Ingredients Capacity of Key Manufacturers in 2015
Figure China Active Pharmaceutical Ingredients Capacity of Key Manufacturers in 2016
Table China Active Pharmaceutical Ingredients Production of Key Manufacturers (2015 and 2016)
Table China Active Pharmaceutical Ingredients Production Share by Manufacturers (2015 and 2016)
Figure 2015 Active Pharmaceutical Ingredients Production Share by Manufacturers
Figure 2016 Active Pharmaceutical Ingredients Production Share by Manufacturers
Table China Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table 2016 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table China Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers in 2015
Table Manufacturers Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area
Table Manufacturers Active Pharmaceutical Ingredients Product Type
Figure Active Pharmaceutical Ingredients Market Share of Top 3 Manufacturers
Figure Active Pharmaceutical Ingredients Market Share of Top 5 Manufacturers
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Novartis International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Merck & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DSM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lonza Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Active Pharmaceutical Ingredients Capacity, Production and Growth (2012-2017)
Figure China Active Pharmaceutical Ingredients Revenue (Million USD) and Growth (2012-2017)
Table China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)
Table China Active Pharmaceutical Ingredients Production by Type (2012-2017)
Table China Active Pharmaceutical Ingredients Production Share by Type (2012-2017)
Figure Production Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure 2015 Production Market Share of Active Pharmaceutical Ingredients by Type
Table China Active Pharmaceutical Ingredients Revenue by Type (2012-2017)
Table China Active Pharmaceutical Ingredients Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure 2015 Revenue Market Share of Active Pharmaceutical Ingredients by Type
Table China Active Pharmaceutical Ingredients Price by Type (2012-2017)
Figure China Active Pharmaceutical Ingredients Production Growth by Type (2012-2017)
Table China Active Pharmaceutical Ingredients Consumption by Application (2012-2017)
Table China Active Pharmaceutical Ingredients Consumption Market Share by Application (2012-2017)
Figure China Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015
Table China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)
Figure China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)
Table China Active Pharmaceutical Ingredients Production by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Production Market Share by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Production Value by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Sales Price by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Consumption by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure China Active Pharmaceutical Ingredients Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Table China Active Pharmaceutical Ingredients Production, Import, Export and Consumption Forecast (2017-2022)
Table China Active Pharmaceutical Ingredients Production Forecast by Type (2017-2022)
Table China Active Pharmaceutical Ingredients Consumption Forecast by Application (2017-2022)
Table China Active Pharmaceutical Ingredients Production Forecast by Regions (Provinces)(2017-2022)
Table China Active Pharmaceutical Ingredients Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...